دورية أكاديمية
AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has Significant Activity in Imatinib-Resistant Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome Positive Acute Lymphoid Leukemia (Ph + ALL).
| العنوان: | AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has Significant Activity in Imatinib-Resistant Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome Positive Acute Lymphoid Leukemia (Ph + ALL). |
|---|---|
| المؤلفون: | Kantarjian, Hagop M., Ottman, O., Cortes, Jorge, Wassman, M., Wunderle, L., Bhalla, K., Jones, D., Hochhaus, A., Rae, P., Alland, L., Dugan, M., Albitar, M., Giles, Francis |
| المصدر: | In Blood 16 November 2005 106(11):37-37 |
| قاعدة البيانات: | ScienceDirect |
| تدمد: | 00064971 |
|---|---|
| DOI: | 10.1182/blood.V106.11.37.37 |